← Eichor
Study identifier: NCT07433959 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neuromodulation to Improve Grasping Function After SCI

Condition: Spinal Cord Injury  ·  Sponsor: State University of New York at Buffalo

PhaseNA
Planned participants54
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

The goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI. The main question it aims to answer is if the inputs to late descending signals above the level of injury and the output of residual late descending signals below the level of injury could be increased. Specifically, in the first part of the study, 30 participants will complete 2 randomized sessions to compare the effect of intermittent theta burst stimulation combined with paired corticospinal motoneuronal stimulation. In the second part of the study, 24 participants will complete either combined stimulation protocol or sham stimulation protocol with exercise training.

This description comes directly from the study's public registry record.

Talk to the study team

Hang Jin Jo, PhD  ·  716-829-2905  ·  hangjinj@buffalo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

The State University of New York at BuffaloBuffalo, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07433959